key: cord-0812619-k4p4vhpy
authors: Kuznetsova, Tatiana; Cauwenberghs, Nicholas
title: Determinants of circulating angiotensin-converting enzyme 2 protein levels in the general population
date: 2020-10-19
journal: Eur J Intern Med
DOI: 10.1016/j.ejim.2020.10.012
sha: 56303e7032954168d53aff61b4f85c27f9aae285
doc_id: 812619
cord_uid: k4p4vhpy

• ACE2 receptor is a crucial for effective replication of infectious SARS-CoV. • We detect a higher ACE2 levels in males, elderly, and those with insulin resistance. • Our findings are in line with clinical reports on severity of SARS‐CoV‐2 in patients.

for variables associated with the ACE2 level using stepwise linear regression. The continuous and categorical variables considered for entry in the stepwise models were sex, age, body mass index (BMI), HOMA-IR, hypertension (yes/no), systolic blood pressure, use of ACE inhibitors (n=27), angiotensin receptor blockers (n=23) or betablockers/diuretics (n=118). We set the P values for variables to enter and to stay in the stepwise regression models at 0.05. To further illustrate statistically significant associations, we reported multivariable-adjusted parameter estimates (±95%CI) for serum ACE2 levels by categories of variables selected in stepwise linear regression.

From the 544 participants (mean age, 57.0±10.4 years; 52.9% women), 274 (50.4%) were hypertensive of whom 164 (30.2%) were on antihypertensive drug treatment. In multivariable stepwise regression analyses, serum ACE2 levels independently and significantly increased with male sex, age and HOMA-IR analyzed continuously (P<0.001 for all). Of note, BMI and hypertension status lost their significance when HOMA-IR was added in the stepwise model (P≥0.13). Indeed, HOMA-IR accounted for most of the explained variances in ACE2 levels (7.8%, <0.0001). Overall, the selected anthropometric covariables (sex and age) and HOMA-IR explained 17.4% of the total variance for ACE2. In support, Fig. 1 presents ACE2 levels by sex, age groups, and HOMA-IR quartiles. Subjects belonging to the fourth quartile of HOMA-IR distribution had significantly higher ACE2 levels as compared to the participants from other quartiles (P≤0.0079).

Taken together, in the general population we observed a significantly higher ACE2 levels in males, in older subjects (>55 years old), and in those with insulin resistance. Our findings are in line with clinical reports on severity of SARS-CoV-2 in elderly subjects, males and patients with obesity and diabetes [3] . Therefore, we suggest that the link between anthropometric and metabolic traits and severe form of SARS-CoV-2 infection might be attributable in some degree to a higher ACE2 levels at baseline which might reflect higher ACE2 expression in tissues and, therefore, higher shedding of ACE2 from the cell membrane. Interestingly, in our cohort of middle-age participants, use of ACE inhibitors and angiotensin receptor blockers was not a significant predictor of circulating ACE2 levels, which is consistent with previous reports in a cohort of patients with symptomatic heart failure [5] . To the best of our knowledge, our study is the first to demonstrate the direct link between the circulating ACE2 and insulin resistance (prediabetes) in the general population. This is in line with previous experimental and clinical studies demonstrating that ACE2 plays of major role in glucose homeostasis. For instance, in non-obese diabetic mice, significant increases in ACE2 activity in serum, pancreas, and heart were observed compared to control mice [6] . With regard to protein expression, ACE2 were increased in lungs and heart at early stage of diabetes [6] . Moreover, associations of type 2 diabetes with increased ACE2 expression in lungs and plasma ACE2 levels were demonstrated in the recent GWAS analysis [7] . Park et al. demonstrated that the urinary ACE2 concentrations were associated with glucose intolerance and T2DM [8] . However, we acknowledge that there is no compelling evidence of a connection between baseline level of circulating ACE2 and the susceptibility to and severity of SARS-CoV-2 infection [9] . Further studies should also clarify the genetic variance in the ACE2 gene and environmental stimuli that might predispose to high levels of ACE2 expression and its concentration, and, therefore, influence the outcome of SARS-CoV-2 infection in the community.

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Obesity: the "Achilles heel" for COVID-19?

Circulating biomarkers predicting longitudinal changes in left ventricular structure and function in a general population

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors

Characterization of ACE and ACE2 expression within different organs of the NOD mouse

Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: a mendelian randomization analysis highlights tentative relevance of diabetes-related traits

High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection